Chen L, Wang J, Wu J, Zheng Q, & Hu J. (2018). Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway. Dove Medical Press.
Chicago Style (17th ed.) CitationChen L, Wang J, Wu J, Zheng Q, and Hu J. Indirubin Suppresses Ovarian Cancer Cell Viabilities Through the STAT3 Signaling Pathway. Dove Medical Press, 2018.
MLA (9th ed.) CitationChen L, et al. Indirubin Suppresses Ovarian Cancer Cell Viabilities Through the STAT3 Signaling Pathway. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.